scholarly journals What about sleep homeostasis in insomnia? Comment on the European guideline for the diagnosis and treatment of insomnia

2017 ◽  
Vol 26 (6) ◽  
pp. 701-701 ◽  
Author(s):  
Daniel Neu ◽  
Olivier Mairesse ◽  
Olivier Le Bon
Keyword(s):  
Diagnosis And Treatment ◽  
European Guideline ◽  
Sleep Homeostasis

scholarly journals European guideline for the diagnosis and treatment of insomnia

2017 ◽  
Vol 26 (6) ◽  
pp. 675-700 ◽  
Author(s):  
Dieter Riemann ◽  
Chiara Baglioni ◽  
Claudio Bassetti ◽  
Bjørn Bjorvatn ◽  
Leja Dolenc Groselj ◽  
...  
Keyword(s):  
Diagnosis And Treatment ◽  
European Guideline

2020 European guideline for the diagnosis and treatment of gonorrhoea in adults

2020 ◽  
pp. 095646242094912
Author(s):  
M Unemo ◽  
JDC Ross ◽  
AB Serwin ◽  
M Gomberg ◽  
M Cusini ◽  
...  
Keyword(s):  
Antimicrobial Susceptibility ◽  
Test Performance ◽  
Evidence Base ◽  
Multidrug Resistant ◽  
Nucleic Acid Amplification ◽  
Diagnosis And Treatment ◽  
Health Concern ◽  
High Dose ◽  
European Guideline ◽  
Treatment Regimens

Gonorrhoea is a major public health concern globally. Increasing incidence and sporadic ceftriaxone-resistant cases, including treatment failures, are growing concerns. The 2020 European gonorrhoea guideline provides up-to-date evidence-based guidance regarding the diagnosis and treatment of gonorrhoea. The updates and recommendations emphasize significantly increasing gonorrhoea incidence; broad indications for increased testing with validated and quality-assured nucleic acid amplification tests and culture; dual antimicrobial therapy including high-dose ceftriaxone and azithromycin (ceftriaxone 1 g plus azithromycin 2 g) OR ceftriaxone 1 g monotherapy (ONLY in well-controlled settings, see guideline for details) for uncomplicated gonorrhoea when the antimicrobial susceptibility is unknown; recommendation of test of cure (TOC) in all gonorrhoea cases to ensure eradication of infection and identify resistance; and enhanced surveillance of treatment failures when recommended treatment regimens have been used. Improvements in access to appropriate testing, test performance, diagnostics, antimicrobial susceptibility surveillance and treatment, and follow-up of gonorrhoea patients are essential in controlling gonorrhoea and to mitigate the emergence and/or spread of ceftriaxone resistance and multidrug-resistant and extensively drug-resistant gonorrhoea. For detailed background, evidence base and discussions, see the background review for the present 2020 European guideline for the diagnosis and treatment of gonorrhoea in adults (Unemo M, et al. Int J STD AIDS. 2020).

ENDORSEMENT OF European guideline for the diagnosis and treatment of insomnia BY THE WORLD SLEEP SOCIETY

2021 ◽  
Author(s):  
Task Force Members ◽  
Guidelines Committee Members ◽  
Charles M. Morin ◽  
Yuchi Inoue ◽  
Clete Kushida ◽  
...  
Keyword(s):  
Diagnosis And Treatment ◽  
European Guideline ◽  
The World

Background review for the ‘2020 European guideline for the diagnosis and treatment of gonorrhoea in adults’

2020 ◽  
pp. 095646242094873
Author(s):  
M Unemo ◽  
JDC Ross ◽  
AB Serwin ◽  
M Gomberg ◽  
M Cusini ◽  
...  
Keyword(s):  
Antimicrobial Susceptibility ◽  
Test Performance ◽  
Evidence Base ◽  
Multidrug Resistant ◽  
Nucleic Acid Amplification ◽  
Diagnosis And Treatment ◽  
Health Concern ◽  
High Dose ◽  
European Guideline ◽  
Treatment Regimens

Gonorrhoea is a major public health concern globally. Increasing incidence and sporadic ceftriaxone-resistant cases, including treatment failures, are growing concerns. The 2020 European gonorrhoea guideline provides up-to-date evidence-based guidance regarding the diagnosis and treatment of gonorrhoea. The updates and recommendations emphasize significantly increasing gonorrhoea incidence; broad indications for increased testing with validated and quality-assured nucleic acid amplification tests (NAATs) and culture; dual antimicrobial therapy including high-dose ceftriaxone and azithromycin (ceftriaxone 1 g plus azithromycin 2 g) OR ceftriaxone 1 g monotherapy (ONLY in well-controlled settings, see guideline for details) for uncomplicated gonorrhoea when the antimicrobial susceptibility is unknown; recommendation of test of cure (TOC) in all gonorrhoea cases to ensure eradication of infection and identify resistance; and enhanced surveillance of treatment failures when recommended treatment regimens have been used. Improvements in access to appropriate testing, test performance, diagnostics, antimicrobial susceptibility surveillance and treatment, and follow-up of gonorrhoea patients are essential in controlling gonorrhoea and to mitigate the emergence and/or spread of ceftriaxone resistance and multidrug-resistant and extensively drug-resistant gonorrhoea. This review provides the detailed background, evidence base and discussions, for the 2020 European guideline for the diagnosis and treatment of gonorrhoea in adults (Unemo M, et al. Int J STD AIDS. 2020).

2012 European guideline on the diagnosis and treatment of gonorrhoea in adults

2013 ◽  
Vol 24 (2) ◽  
pp. 85-92 ◽  
Author(s):  
C Bignell ◽  
M Unemo ◽  
Keith Radcliffe ◽  
Jørgen Skov Jensen ◽  
Karen Babayan ◽  
...  
Keyword(s):  
Diagnosis And Treatment ◽  
European Guideline

Aortic root aneurysm. Diagnosis and treatment

JAMA ◽  
1966 ◽  
Vol 197 (2) ◽  
pp. 133-134 ◽  
Author(s):  
H. Najafi
Keyword(s):  
Aortic Root ◽  
Diagnosis And Treatment ◽  
Aortic Root Aneurysm
Sign in / Sign up

Export Citation Format

Share Document